BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2855727)

  • 21. Fluconazole.
    Med Lett Drugs Ther; 1990 May; 32(818):50-2. PubMed ID: 2185400
    [No Abstract]   [Full Text] [Related]  

  • 22. [Opportunistic mycotic infections in AIDS. Brief review and presentation of 2 clinical cases].
    Michelone G; Senaldi G; Di Perri G; Dei Cas A; Cavanna C; Minoli L
    G Ital Chemioter; 1986; 33(2-3):75-82. PubMed ID: 3315812
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical and mycological responses to fluconazole and fluconazole MIC in oropharyngeal candidiasis in HIV-infected patients.
    Bussaratid V; Tansupasawasdikul S; Simpson A; Pitisuttithum P; Phonrat B; Howe P; White NJ
    J Med Assoc Thai; 2002 Jul; 85(7):757-64. PubMed ID: 12296406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluconazole for the management of invasive candidiasis: where do we stand after 15 years?
    Charlier C; Hart E; Lefort A; Ribaud P; Dromer F; Denning DW; Lortholary O
    J Antimicrob Chemother; 2006 Mar; 57(3):384-410. PubMed ID: 16449304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients.
    Ally R; Schürmann D; Kreisel W; Carosi G; Aguirrebengoa K; Dupont B; Hodges M; Troke P; Romero AJ;
    Clin Infect Dis; 2001 Nov; 33(9):1447-54. PubMed ID: 11577374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal allograft loss due to overwhelming invasive Candida infection.
    Stolk MJ; King AL; Massey HD
    Kidney Int; 2010 Apr; 77(8):746. PubMed ID: 20354557
    [No Abstract]   [Full Text] [Related]  

  • 27. Single-dose fluconazole versus standard 2-week therapy for oropharyngeal candidiasis in HIV-infected patients: a randomized, double-blind, double-dummy trial.
    Hamza OJ; Matee MI; Brüggemann RJ; Moshi MJ; Simon EN; Mugusi F; Mikx FH; van der Lee HA; Verweij PE; van der Ven AJ
    Clin Infect Dis; 2008 Nov; 47(10):1270-6. PubMed ID: 18840077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluconazole for the treatment of fungal diseases in immunosuppressed patients.
    Dupont B; Drouhet E
    Ann N Y Acad Sci; 1988; 544():564-70. PubMed ID: 2850757
    [No Abstract]   [Full Text] [Related]  

  • 29. Lack of cross-hepatotoxicity between fluconazole and voriconazole.
    Spellberg B; Rieg G; Bayer A; Edwards JE
    Clin Infect Dis; 2003 Apr; 36(8):1091-3. PubMed ID: 12684933
    [No Abstract]   [Full Text] [Related]  

  • 30. [Focusing on therapy of systemic mycoses].
    Internist (Berl); 1995 Dec; 36(12 Suppl):1-12. PubMed ID: 9022383
    [No Abstract]   [Full Text] [Related]  

  • 31. [Curative treatment with fluconazole in 5 cases of invasive candidiasis].
    Martínez-Marcos FJ; Jiménez-Mejías ME; Moreno-Maqueda I; Caballero-Granado J; Rodríguez-Hernández MJ; Pachón-Díaz J
    Enferm Infecc Microbiol Clin; 1996 Nov; 14(9):541-4. PubMed ID: 9035711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The gastroenterological manifestations of AIDS and HIV infection.
    Miller AR
    J R Nav Med Serv; 1986; 72(3):129-34. PubMed ID: 3312592
    [No Abstract]   [Full Text] [Related]  

  • 33. [What is reliable in the therapy of cryptococcal meningitis?].
    Glück T; Weber P; Dölle W
    Internist (Berl); 1991 Dec; 32(12):729-31. PubMed ID: 1783515
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical efficacy of fluconazole in urinary tract fungal infections].
    Nito H
    Jpn J Antibiot; 1989 Jan; 42(1):171-8. PubMed ID: 2540364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Posaconazole for azole-refractory candidiasis in patients with HIV infection.
    Winslow DL
    AIDS Alert; 2007 May; 22(5):59-60. PubMed ID: 17577961
    [No Abstract]   [Full Text] [Related]  

  • 36. Combination therapy with antifungal drugs.
    Polak A
    Mycoses; 1988; 31 Suppl 2():45-53. PubMed ID: 3067091
    [No Abstract]   [Full Text] [Related]  

  • 37. [Cryptococcal meningoencephalitis related to HIV infection with resistance to fluconazole, relapse, and IRIS].
    Seilmaier M; Hecht A; Guggemos W; Rüdisser K
    Med Klin (Munich); 2009 Jan; 104(1):58-62. PubMed ID: 19142596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Emergency of fluconazole-resistant infections by Candida krusei and Candida glabrata in neutropenic patients].
    Piemonte P; Conte G; Flores C; Barahona O; Araos D; Alfaro J; Fardella P; Thompson L
    Rev Med Chil; 1996 Sep; 124(9):1149. PubMed ID: 9197032
    [No Abstract]   [Full Text] [Related]  

  • 39. Fluconazole as prophylaxis against fungal infection in patients with advanced HIV infection.
    Manfredi R; Mastroianni A; Coronado OV; Chiodo F
    Arch Intern Med; 1997 Jan; 157(1):64-9. PubMed ID: 8996042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fluconazole antifungal agent.
    Habert M
    Aust Nurses J; 1992 Oct; 22(4):27-8. PubMed ID: 1299181
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.